StockNews.com began coverage on shares of Seagen (NASDAQ:SGEN – Free Report) in a report published on Sunday morning. The brokerage issued a hold rating on the biotechnology company’s stock. A number of other brokerages also recently weighed in on SGEN. TheStreet downgraded Seagen from a c- rating to a d+ rating in a report on […]
E Fund Management Co. Ltd. reduced its holdings in shares of Seagen Inc. (NASDAQ:SGEN – Free Report) by 4.8% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 3,713 shares of the biotechnology company’s stock after selling 189 shares during […]
Capital International Ltd. CA lowered its stake in shares of Seagen Inc. (NASDAQ:SGEN – Free Report) by 48.9% in the second quarter, according to its most recent disclosure with the SEC. The fund owned 62,051 shares of the biotechnology company’s stock after selling 59,478 shares during the period. Capital International Ltd. CA’s holdings in Seagen […]
ProShare Advisors LLC cut its stake in Seagen Inc. (NASDAQ:SGEN – Free Report) by 6.2% during the 2nd quarter, Holdings Channel.com reports. The institutional investor owned 159,730 shares of the biotechnology company’s stock after selling 10,558 shares during the period. ProShare Advisors LLC’s holdings in Seagen were worth $30,742,000 as of its most recent filing […]
Rhumbline Advisers grew its position in Seagen Inc. (NASDAQ:SGEN – Free Report) by 19.1% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 200,036 shares of the biotechnology company’s stock after buying an additional 32,071 shares during the quarter. Rhumbline Advisers owned […]